Innovating Works

filtrando por convocatoria: HORIZON-HLTH-2021-DISEASE-04-04

Mostrando 21 al 32 de 32 resultados
HERVCOV: SARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personali... INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 Severe COVID-19 disease and the high frequency of its long-term complications are now a major health problem worldwide. Due to the significa...
2022-07-01 - 2027-06-30 | Financiado
HORUS: Casting light on HOst-cytomegaloviRUs interaction in Solid organ transplantation UNIVERSITE DE BORDEAUX tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 "Solid organ transplantation (SOT) is the treatment of choice for end-stage organ failure but the immunosuppressive drugs used to prevent gr...
2022-11-01 - 2027-10-31 | Financiado
PvSTATEM: SEROLOGICAL TESTING AND TREATMENT FOR P. VIVAX: FROM A CLUSTER-RANDOMISED TRIAL IN ETHIOPIA AND MADA... INSTITUT PASTEUR tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 P. vivax is considered the most difficult human malaria to eliminate because of the inability of conventional diagnostics to detect individu...
2022-10-01 - 2027-09-30 | Financiado
AICE: AI supported picture analysis in large bowel camera capsule endoscopy REGION SYDDANMARK tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 Millions of Europeans undergo optical colonoscopy (OC) every year. OC may be associated with discomfort, complications and sick-days, which...
2022-09-01 - 2026-08-31 | Financiado
SERENITY: Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life ACADEMISCH ZIEKENHUIS LEIDEN tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 Despite the fact that antithrombotic therapy (ATT) has little or even negative effects on the well-being of cancer patients during their las...
2022-10-01 - 2027-09-30 | Financiado
TOLIFE: Combining Artificial Intelligence and smart sensing TOward better management and improved quality of... UNIVERSITA DI PISA tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 Chronic obstructive pulmonary disease (COPD) is a highly prevalent chronic condition. While COPD is a lung disease, it is mainly the exacerb...
2022-09-01 - 2027-02-28 | Financiado
AISN: Integrating AI in Stroke Neurorehabilitation STICHTING RADBOUD UNIVERSITEIT tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 Health services are increasingly moving towards a treatment continuum aligned with the patient journey. This transition will critically depe...
2022-12-01 - 2026-11-30 | Financiado
DESIGN OH AMR: DESIGNing the European Partnership on One Health AMR VETENSKAPSRADET SWEDISH RESEARCH COUNCIL tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 At the highest political levels antimicrobial resistance (AMR) is recognised as major threat to the health of citizens and societies, food s...
2022-05-01 - 2024-09-30 | Financiado
BE READY: Building a European strategic Research and Innovation Area in Direct Synergy with EU and Internation... INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 The COVID-19 pandemic has confirmed and further highlighted the importance of planning and investing in research and innovation well before...
2022-06-01 - 2025-05-31 | Financiado
PRE-ACT: PRE ACT Prediction of Radiotherapy side Effects using explainable AI for patient Communication and... National Gallery of Athens - Alexandros Soutsos Museum tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 Radiotherapy is a widely used cancer treatment, however some patients suffer side effects. In breast cancer, side effects can include breast...
2022-05-23 - 2027-09-30 | Financiado
CLASSICA: VALIDATING AI IN CLASSIFYING CANCER IN REAL-TIME SURGERY UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 Building on breakthrough research in the AI analysis of fluorescence and perfusion in cancer tissues, this project clinically validates the...
2022-05-19 - 2026-04-30 | Financiado
MELISSA: Mobile Artificial Intelligence Solution for Diabetes Adaptive Care UNIVERSITEIT MAASTRICHT tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 The MELISSA project aims to provide a clinically validated, effective, trustworthy, and cost-efficient artificial intelligence (AI)-based di...
2022-05-23 - 2026-05-31 | Financiado